Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pain × Injections × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 25 Advanced Solid Tumors 18 Breast Neoplasms 12 Myelodysplastic Syndromes 11 Neoplasms 10 Advanced Solid Tumor 10 Prostatic Neoplasms 9 Solid Tumor 7 Neoplasm Metastasis 7 Multiple Myeloma 7 Recurrence 6 Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Melanoma 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia 4 Solid Tumors 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Neoplasms 3 Lung Neoplasms 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Primary Myelofibrosis 2 Nasopharyngeal Carcinoma 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, Non-Hodgkin 2 Lymphoma, B-Cell 2

Interventions

Methadone 3 Cryotherapy 3 Cryosurgery 3 Oxycodone 2 trimebutine 3-thiocarbamoylbenzenesulfonate 1 piperine 1 Sodium Bicarbonate 1 Rosuvastatin Calcium 1 Radiotherapy 1 Radiation 1 Propofol 1 Photochemotherapy 1 Olive Oil 1 Morphine 1 Massage 1 Lidocaine 1 Laser Therapy 1 Injections 1 Hydromorphone 1 Gabapentin 1 Electroencephalography 1 Dronabinol 1 Dexamethasone 1 Curcumin 1 Control Groups 1 Calcium Dobesilate 1 Analgesia, Epidural 1 Amidines 1 Acupuncture Therapy 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01482936 2015-08-11

Pharmacokinetic (PK) Study of OxyNorm Injections in Chinese Patient

Mundipharma (China) Pharmaceutical Co. Ltd

Phase 1 Completed

Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡